Mitral Valve Repair for the Treatment of Acute Bacterial Endocarditis: Analysis of a 10-Year Single-Center Experience
Open Access
- 7 November 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 7907
Abstract
Background/Objectives: Acute bacterial endocarditis (ABE) is a frequent situation and continues to be a challenge. Mitral valve involvement during acute bacterial endocarditis is often the result of the spread of the endocarditic process from the adjacent aortic valve. Mitral involvement, on the other hand, could also be an expression of the initial localization of the bacteria. The best option for treating mitral ABE is still a matter of debate. Recent reports have shown satisfactory results with mitral reconstructive techniques in the treatment of mitral ABE. In this study, we present a comprehensive review of our 10-year institutional experience in the surgical management of acute mitral endocarditis with a focus on technical considerations, outcomes, and the durability of mitral valve repair in this high-risk population. Methods: We queried the institutional database, cross-referencing patients admitted with a diagnosis of “acute bacterial endocarditis” with patients undergoing surgical procedures for “valvular disease” at our division. Out of 1136 valvular procedures listed in our PACS database, 180 patients were admitted with a diagnosis of active acute endocarditis, and 46 included treatment of the mitral valve. We analyzed and compared short- and long-term follow-up (ranging from 3 to 141 months with a mean of 42 ± 38 months) of these 46 patients, dividing them into two groups: mitral valve repair (MVr) and mitral valve replacement (MVR). Results: 18 (40%) patients underwent reconstructive treatment of the mitral valve, and 28 (60%) underwent mitral valve replacement. Cumulative in-hospital mortality was 10% (5 pts, all from the MVR group), however, with no difference between the two groups. A shorter time gap from diagnosis to surgery (60 years), and urgent surgical procedures. Finally, patients with MVr also experienced a favorable postoperative event-free curve for endocarditis recurrence (p = 0.0260) and time elapsed before recurrence (p = 0.0438). Conclusions: Mitral valve repair in the case of active endocarditis could be a treatment associated with more favorable outcomes, providing that a complete eradication of infective tissue can be accomplished. Conservative treatment, when feasible, seems to offer favorable cumulative long-term outcomes.Keywords
This publication has 37 references indexed in Scilit:
- Trends in epidemiology, surgical management, and prognosis of infective endocarditis during the XXI century in Spain: A population-based nationwide studyJournal of Infection and Public Health, 2024
- Species designation of streptococci causing infective endocarditis in patients with mitral valve prolapseInternational Journal of Infectious Diseases, 2023
- Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve SurgeryInfectious Diseases and Therapy, 2022
- Role of Mitral Valve Repair for Mitral Infective EndocarditisCardiology Clinics, 2021
- Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective EndocarditisCanadian Journal of Cardiology, 2021
- Extending the scope of mitral valve repair in active endocarditisThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Surgical results of active infective native mitral valve endocarditis: repair versus replacementEuropean Journal of Cardio-Thoracic Surgery, 2011
- Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience☆European Journal of Cardio-Thoracic Surgery, 2007
- Surgical treatment of active infective endocarditis: A continued challengeThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Valve repair in acute endocarditisThe Annals of Thoracic Surgery, 1990